Abstract
Twenty-one patients in severe congestive heart failure refractory to conventional medical management were treated with sodium nitroprusside on 22 occasions. On 14 occasions (responders) there was significant improvement in clinical and haemodynamic indices. On 8 occasions (non-responders) hypotension developed without haemodynamic improvement and nitroprusside treatment had to be abandoned. The initial mean arterial pressure and the capillary wedge pressure tended to be higher in the responders while the cardiac index tended to be higher in the non-responders. The systemic vascular resistance was higher in the responders than in the non-responders (2560 +/- 160 vs 1800 +/- 180 dynes s cm-5, P less than 0.001). All of the responders had systemic vascular resistance greater than 1900 dynes s cm-5, while only one of the non-responders had a systemic vascular resistance in this range. Thus, a variable response to vasodilator therapy for congestive cardiac failure is documented. The favourable response appears to be limited to patients with a high systemic vascular resistance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chatterjee K., Parmley W. W., Ganz W., Forrester J., Walinsky P., Crexells C., Swan H. J. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation. 1973 Dec;48(6):1183–1193. doi: 10.1161/01.cir.48.6.1183. [DOI] [PubMed] [Google Scholar]
- Chatterjee K., Parmley W. W., Swan H. J., Berman G., Forrester J., Marcus H. S. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation. 1973 Oct;48(4):684–690. doi: 10.1161/01.cir.48.4.684. [DOI] [PubMed] [Google Scholar]
- Cohn J. N. Blood pressure and cardiac performance. Am J Med. 1973 Sep;55(3):351–361. doi: 10.1016/0002-9343(73)90135-6. [DOI] [PubMed] [Google Scholar]
- Cohn J. N. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance. Circulation. 1973 Jul;48(1):5–8. doi: 10.1161/01.cir.48.1.5. [DOI] [PubMed] [Google Scholar]
- Falicov R. E., Resnekov L. Relationship of the pulmonary artery end-diastolic pressure to the left ventricular end-diastolic and mean filling pressures in patients with and without left ventricular dysfunction. Circulation. 1970 Jul;42(1):65–73. doi: 10.1161/01.cir.42.1.65. [DOI] [PubMed] [Google Scholar]
- Franciosa J. A., Limas C. J., Guiha N. H., Rodriguera E., Cohn J. N. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet. 1972 Mar 25;1(7752):650–654. doi: 10.1016/s0140-6736(72)90460-6. [DOI] [PubMed] [Google Scholar]
- Guiha N. H., Cohn J. N., Mikulic E., Franciosa J. A., Limas C. J. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med. 1974 Sep 19;291(12):587–592. doi: 10.1056/NEJM197409192911201. [DOI] [PubMed] [Google Scholar]
- Majid P. A., Sharma B., Taylor S. H. Phentolamine for vasodilator treatment of severe heart-failure. Lancet. 1971 Oct 2;2(7727):719–724. doi: 10.1016/s0140-6736(71)92098-8. [DOI] [PubMed] [Google Scholar]
- Miller R. R., Vismara L. A., Zelis R., Amsterdam E. A., Mason D. T. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Circulation. 1975 Feb;51(2):328–336. doi: 10.1161/01.cir.51.2.328. [DOI] [PubMed] [Google Scholar]
- Palmer R. F., Lasseter K. C. Drug therapy. Sodium nitroprusside. N Engl J Med. 1975 Feb 6;292(6):294–297. doi: 10.1056/NEJM197502062920606. [DOI] [PubMed] [Google Scholar]
- Resnekov L., Lipp H. Circulatory effects of acute myocardial infarction as a rational basis for therapy. Ann Clin Res. 1971 Dec;3(6):362–376. [PubMed] [Google Scholar]